IDO1 and neoplasm: Additionally, recent preclinical evidence indicates that the IDO1 inhibitors synergize the effects of tumor immuno- and chemotherapies and help to solve the problem of tumor resistance against them [83,93,105,106,107,108,112,113,119,120,129,132,133,136,137,143,146,151,154,155,156,157,171].